Research New Discovery Enables Gene Therapy for Muscular Dystrophies, Other Disorders By Emily Boynton Nov. 14, 2024 Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size. The genes that are dysfunctional in muscular ...
People The Albany Prize Awarded to Biochemist Lynne Maquat By Emily Boynton Oct. 8, 2024 One of the nation's largest and most distinguished prizes in medicine, Maquat received the award for her research on RNA mechanisms that contribute to a wide range of diseases.
People Lynne Maquat Receives 2024 Dr. Paul Janssen Award By Emily Boynton Sep. 24, 2024 The director of the University of Rochester Center for RNA Biology is honored for her fundamental discoveries about RNA decay in the context of human diseases.
Research RNA Center of Excellence to Develop New Treatments, Train Future Scientists By Emily Boynton May. 9, 2024 The field of RNA biology has catapulted to the forefront of health and medicine over the past decade as the work of scientists like Lynne E. Maquat, PhD, director of the University of Rochester ...
Research A Search Engine for mRNA: Algorithm Identifies Optimal Sequences to Improve COVID Vaccines By Emily Boynton May. 19, 2023 Messenger RNA vaccines proved their worth in the COVID pandemic, and new software stands to make the already transformative technology even more powerful.
Research Study: Scientists Harness Power, Precision of RNA to Make Mutations Invisible By Emily Boynton Mar. 6, 2023 Researchers in the UR Center for RNA Biology discovered a new way to suppress mutations that lead to a wide range of genetic disorders, such as cystic fibrosis, muscular dystrophy and many forms of ...
Research RNA Biologist Lynne Maquat Awarded 2023 Gruber Genetics Prize By Emily Boynton Feb. 23, 2023 The founding director of the Center for RNA Biology at the University of Rochester received the award for her discovery of nonsense-mediated mRNA decay (NMD) in humans.
Research Double Duty: Early Research Reveals how a Single Drug Delivers Twice the Impact in Fragile X By Emily Boynton Jun. 27, 2022 In a new study in the journal Molecular Cell, scientists found that a drug being tested in cancer clinical trials affected stem cells that mimic fragile X syndrome.
Research The Last Mile By Scott Hesel Dec. 6, 2021 New treatment therapies, mRNA, and improved Complex Care services have significantly improved the quality of life of Cystic Fibrosis patients at URMC.
People Lynne Maquat Wins Warren Alpert Foundation Prize By Emily Boynton May. 3, 2021 The professor of Biochemistry and Biophysics, Oncology and Pediatrics was honored for her pivotal discoveries in the field of RNA biology. The prize is administered by Harvard Medical School and ...